Nico Pfeifer

Nico Pfeifer

Auto-generated profile, based on publicly available information

Nico Pfeifer

Methods in Medical Informatics, Department of Computer Science, University of Tübingen, 72076 Tübingen, Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2008 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MSMarc Sturm
Marc Sturm
ABAndreas Bertsch
Andreas Bertsch
CGClemens Gröpl
Clemens Gröpl
AHAndreas Hildebrandt
Andreas Hildebrandt
RHRene Hussong
Rene Hussong
OKOliver Kohlbacher
Oliver Kohlbacher
Mass spectrometry is an essential analytical technique for high-throughput analysis in proteomics and metabolomics. The development of new separation techniques, precise mass analyzers and experimental protocols is a very active field of research. This leads to more complex experimental setups yielding ever increasing amounts of data. Consequently, analysis of the data is currently often the bottleneck for experimental studies. Although software tools for many data analysis tasks are available today, they are often hard to combine with each other or not flexible enough to allow for rapid prototyping of a new analysis workflow. We present OpenMS, a software framework for rapid application development in mass spectrometry. OpenMS has been designed to be portable, easy-to-use and robust while offering a rich functionality ranging from basic data structures to sophisticated algorithms for data analysis. This has already been demonstrated in several studies. OpenMS is available under the Lesser GNU Public License (LGPL) from the project website at http://www.openms.de .

16 January 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MCMarina Caskey
Marina Caskey
TSTill Schoofs
Till Schoofs
HGHenning Gruell
Henning Gruell
ASAllison Settler
Allison Settler
TKTheodora Karagounis
Theodora Karagounis
FKFlorian Klein
Florian Klein

22 June 2016 in Nature
Verified
Journal Article
Closed access
PDF file
JSJohannes F. Scheid
Johannes F. Scheid
JHJoshua A. Horwitz
Joshua A. Horwitz
YBYotam Bar-On
Yotam Bar-On
EKEdward F. Kreider
Edward F. Kreider
CLChing-Lan Lu
Ching-Lan Lu
MCMarina Caskey
Marina Caskey

20 May 2016 in Science
Verified
Journal Article
Closed access
PDF file
TSTill Schoofs
Till Schoofs
FKFlorian Klein
Florian Klein
MBMalte Braunschweig
Malte Braunschweig
EKEdward F. Kreider
Edward F. Kreider
AFAnna Feldmann
Anna Feldmann
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Insights into antibody therapy for HIV-1: Despite the success of antiretroviral therapy, HIV-1-infected individuals still harbor latent virus. Thus, other therapeutic strategies are needed. A single injection of a broad and potent monoclonal antibody targeting the HIV-1 envelope protein reduced viral loads in HIV-1-infected individuals, albeit only transiently. Lu et al. now report that antibody treatment not only blocked free virus from infecting new cells, it also accelerated the clearance of infected cells. Furthermore, Schoofs et al. demonstrate that therapeutic antibody treatment enhanced infected individuals' humoral response against the virus. Thus, neutralizing antibodies may be a promising therapy for HIV-1 because of their potential to reduce the viral reservoir. Science , this issue pp. 1001 and 997

15 January 2007 in Bioinformatics
Verified
Journal Article
Open access
PDF file
OKOliver Kohlbacher
Oliver Kohlbacher
KRKnut Reinert
Knut Reinert
CGClemens Gröpl
Clemens Gröpl
ELEva Lange
Eva Lange
NPNico Pfeifer
Nico Pfeifer
MSMarc Sturm
Marc Sturm
Motivation: Experimental techniques in proteomics have seen rapid development over the last few years. Volume and complexity of the data have both been growing at a similar rate. Accordingly, data management and analysis are one of the major challenges in proteomics. Flexible algorithms are required to handle changing experimental setups and to assist in developing and validating new methods. In order to facilitate these studies, it would be desirable to have a flexible ‘toolbox’ of versatile and user-friendly applications allowing for rapid construction of computational workflows in proteomics. Results: We describe a set of tools for proteomics data analysis—TOPP, The OpenMS Proteomics Pipeline. TOPP provides a set of computational tools which can be easily combined into analysis pipelines even by non-experts and can be used in proteomics workflows. These applications range from useful utilities (file format conversion, peak picking) over wrapper applications for known applications (e.g. Mascot) to completely new algorithmic techniques for data reduction and data analysis. We anticipate that TOPP will greatly facilitate rapid prototyping of proteomics data evaluation pipelines. As such, we describe the basic concepts and the current abilities of TOPP and illustrate these concepts in the context of two example applications: the identification of peptides from a raw dataset through database search and the complex analysis of a standard addition experiment for the absolute quantitation of biomarkers. The latter example demonstrates TOPP's ability to construct flexible analysis pipelines in support of complex experimental setups. Availability: The TOPP components are available as open-source software under the lesser GNU public license (LGPL). Source code is available from the project website at Author Webpage Contact:oliver.kohlbacher@uni-tuebingen.de

29 October 2013 in eLife
Verified
Journal Article
Open access
IBIstván Bartha
István Bartha
JCJonathan M Carlson
Jonathan M Carlson
CBChanson J Brumme
Chanson J Brumme
PMPaul J McLaren
Paul J McLaren
ZBZabrina L Brumme
Zabrina L Brumme
JFJacques Fellay
Jacques Fellay
HIV-1 sequence diversity is affected by selection pressures arising from host genomic factors. Using paired human and viral data from 1071 individuals, we ran >3000 genome-wide scans, testing for associations between host DNA polymorphisms, HIV-1 sequence variation and plasma viral load (VL), while considering human and viral population structure. We observed significant human SNP associations to a total of 48 HIV-1 amino acid variants (p<2.4 × 10−12). All associated SNPs mapped to the HLA class I region. Clinical relevance of host and pathogen variation was assessed using VL results. We identified two critical advantages to the use of viral variation for identifying host factors: (1) association signals are much stronger for HIV-1 sequence variants than VL, reflecting the ‘intermediate phenotype’ nature of viral variation; (2) association testing can be run without any clinical data. The proposed genome-to-genome approach highlights sites of genomic conflict and is a strategy generally applicable to studies of host–pathogen interaction.